Comparison of Oral Fluconazole and Itraconazole for Progressive, Nonmeningeal Coccidioidomycosis
Annals of Internal MedicinePublished 7 November 2000
John N. Galgiani, Antonino Catanzaro, Gretchen A. Cloud, Royce H. Johnson, Paul L. Williams, Laurence F. Mirels
Citations288
SJR quartileQ1
SJR score3.38
SNIP3.27
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The findings from Mycoses Study Group Protocol 20, a comparative trial sponsored by the National Institute of Allergy and Infectious Diseases that compares two antifungal agents, fluconazole and itraconazole, in the treatment of coccidioidomycosis, are presented.
Abstract
Neither fluconazole nor itraconazole showed statistically superior efficacy in nonmeningeal coccidioidomycosis, although there is a trend toward slightly greater efficacy with itraconazole at the doses studied.
Keywords
Medicine
Springer series in statisticsNonparametric Estimation from Incomplete Observations
45,533 Citations1992Edward L. Kaplan, Paul Meier
Journal of the American Statistical AssociationNonparametric Estimation from Incomplete Observations
39,052 Citations1958Edward L. Kaplan, Paul Meier
BiometrikaDiscrete sequential boundaries for clinical trials
1,740 Citations1983K. K. Gordon Lan, David L. DeMets
A more flexible way to construct discrete sequential boundaries is proposed, based on the choice of a function, a*(t), which characterizes the rate at which the error level ac is spent.
DrugsFluconazole
658 Citations1990Susan Grant, Stephen P. Clissold
The promising clinical response of patients with various forms of candidiasis or cryptococcosis recommends fluconazole as a useful addition to currently available systemic antifungal therapies, in particular for the treatment of mycoses in patients with AIDS.
The American Journal of MedicineTreatment of invasive aspergillosis with itraconazole
365 Citations1989David W. Denning, Richard Tucker +2 more
This experience suggests itraconazole may be an important advance in the therapy of aspergillosis, in contrast to previously available therapy.
DrugsItraconazole
360 Citations1989Susan Grant, Stephen P. Clissold
Preliminary findings indicate that itraconazole may hold promise for the prophylaxis of opportunistic fungal infections in patients at risk, for example women with chronic recurrent vaginal candidiasis, immunodeficient patients with chronic mucocutaneous candidiasis, AIDS patients and patients receiving immunosuppressant drugs.
Clinical Infectious DiseasesPractice Guidelines for the Treatment of Coccidioidomycosis
278 Citations2000J N Galgiani, Neil M. Ampel +4 more
Management of patients diagnosed with coccidioidomycosis involves defining the extent of infection and assessing host factors that predispose to disease severity, which may include antifungal therapy, surgical debridement, or both.
Annals of Internal MedicineFluconazole Therapy for Coccidioidal Meningitis
206 Citations1993John N. Galgiani, Antonino Catanzaro +6 more
A collaborative study of the treatment of coccidioidal meningitis with fluconazole corroborate those of earlier investigations and offer guidance for future studies.
The American Journal of MedicineItraconazole treatment of coccidioidomycosis
165 Citations1990John R. Graybill, David A. Stevens +3 more
Itraconazole appears efficacious and very well tolerated in patients with coccidioidomycosis.
Annals of Internal MedicineCoccidioidomycosis: A Regional Disease of National Importance: Rethinking Approaches for Control
165 Citations1999John N. Galgiani
Because of the increasing application of organ transplantation and the spread of the AIDS epidemic, coccidioidomycosis has become a common opportunistic infection in endemic areas and a growing segment of persons unusually susceptible to the most serious consequences of infection has also emerged.
Annals of Internal MedicineItraconazole Therapy for Chronic Coccidioidal Meningitis
152 Citations1990Richard Tucker, David W. Denning +2 more
Itraconazole shows impressive activity in this series of patients with refractory coccidioidal meningitis, and should be evaluated further.
Clinical Infectious DiseasesA Pan-American 5-Year Study of Fluconazole Therapy for Deep Mycoses in the Immunocompetent Host
138 Citations1992Manuel Concha Díaz, Ricardo Negroni +9 more
In vitro susceptibility tests suggested that clinical response was correlated with susceptibility but that resistance did not preclude clinical response, and fluconazole therapy appears efficacious for several deep mycoses; dosages of greater than 200 mg daily may be needed for some diseases.
The American Journal of MedicineFluconazole in the treatment of chronic pulmonary and nonmeningeal disseminated coccidioidomycosis
137 Citations1995Antonino Catanzaro, John N. Galgiani +6 more
Fluconazole 200 or 400 mg/d is well tolerated and a moderately effective treatment for chronic pulmonary or nonmeningeal disseminated coccidioidomycosis and the relapse rate following therapy is high.
Annals of Internal MedicineHigh-Dose Ketoconazole for Treatment of Fungal Infections of the Central Nervous System
101 Citations1983Philip C. Craven, JOHN R. GRAYBILL +3 more
The encouraging clinical responses, convenience, safety, and the consistent penetration of ketoconazole into obstructed and nonobstructed cerebrospinal fluid support the use of these regimens as alternatives to conventional therapy.
Antimicrobial Agents and ChemotherapyActivity of the triazole SCH 56592 against disseminated murine coccidioidomycosis
100 Citations1997J E Lutz, Karl V. Clemons +2 more
SCH 56592 is a new triazole antifungal with a broad spectrum of activity that has potent, fungicidal activity in vivo against C. immitis and should be considered for clinical trials in patients with coccidioidomycosis.
The American Journal of MedicineKetoconazole therapy of progressive coccidioidomycosis
92 Citations1988John N. Galgiani, David A. Stevens +3 more
It is concluded that ketoconazole in doses above those currently recommended offer little or no benefit for most patients with non-meningeal forms of coccidioidomycosis.
Clinical Infectious DiseasesTreatment of Coccidioidal Meningitis with Fluconazole
87 Citations1990Richard Tucker, John N. Galgiani +9 more
Fluconazole continues to show promise even as sole therapy against coccidioidal meningitis, and not all patients respond, however, and relapse may be a problem with the currently studied doses and durations of therapy.
Antimicrobial Agents and ChemotherapyDiscrepancies in bioassay and chromatography determinations explained by metabolism of itraconazole to hydroxyitraconazole: studies of interpatient variations in concentrations
87 Citations1993J.S. Hostetler, J. Heykants +4 more
It is shown that concentrations of a hydroxylated metabolite, hydroxyitraconazole (HIZ), are approximately twofold higher than IZ over a range of concentrations, explaining discrepancies observed between assay methods.
Journal of the American Academy of DermatologyItraconazole therapy for nonmeningeal coccidioidomycosis: Clinical and laboratory observations
80 Citations1990Richard Tucker, David W. Denning +3 more
Itraconazole shows impressive activity in this series of patients with refractory coccidioidomycosis, and clinical isolates of Coccidioides immitis showed uniform in vitro susceptibility to the antifungal agent.
Clinical Infectious DiseasesTreatment of Coccidioidomycosis with Ketoconazole: Clinical and Laboratory Studies of 18 Patients
69 Citations1980John R. Graybill, D. Lundberg +4 more
It is suggested that ketoconazole may be effective for treatment of this disease and indicate that trials comparing the efficacy of ketconazole with that of amphotericin B are warranted.
Annals of Internal MedicineAlopecia Associated with Fluconazole Therapy
66 Citations1995Peter G. Pappas, Carol A. Kauffman +8 more
33 patients who developed reversible alopecia temporally associated with extended fluconazole use for fungal disease are reported on.
The American Journal of MedicineExperience with ketoconazole in three major manifestations of progressive coccidioidomycosis
64 Citations1983David A. Stevens, Robert L. Stiller +2 more
Ketoconazole appears to be an important advance in the therapy of chronic coccidioidomycosis, and whether cure is possible will require further study and follow-up.
Annals of Internal MedicineKetoconazole for Treatment of Disseminated Coccidioidomycosis
63 Citations1982Antonino Catanzaro, HANS EINSTEIN +5 more
Ketoconazole seems to suppress but not eradicate C. immitis, and the drug may be able to stabilize the infection while cell-mediated immunity is restored.
Antimicrobial Agents and ChemotherapyAssay of fluconazole by megabore capillary gas-liquid chromatography with nitrogen-selective detection
54 Citations1989S.C. Harris, Jack Wallace +2 more
A megabore column gas-liquid chromatographic method which uses nitrogen-phosphorus detection was developed for the analysis of fluconazole in plasma, serum, cerebrospinal fluid, or urine and the suitability of the assay for pharmacokinetic studies was demonstrated.
Journal of Clinical MicrobiologyComparison of immunodiffusion techniques with standard complement fixation assay for quantitation of coccidioidal antibodies
52 Citations1983Marion A. Wieden, J N Galgiani +1 more
Quantitative immunodiffusion measurement of coccidioidal antibodies may be a useful substitute for the CF assay in certain clinical laboratories.
Clinical Infectious DiseasesTherapy of Disseminated or Pulmonary Coccidioidomycosis with Ketoconazole
52 Citations1980Corstiaan Brass, J N Galgiani +2 more
The data show that ketoconazole appears to be a promising new drug for treatment of coccidioidomycosis, and patients who responded to therapy required more than three months of treatment before the response was clearly noted.
The American Journal of MedicineKetoconazole treatment of nonprimary coccidioidomycosis
48 Citations1982Richard DeFelice, John N. Galgiani +8 more
The use of ketoconazole in the treatment of certain forms of chronic coccidioidal infections is supported, and responses were evaluated in relation to the predominant site of involvement.
CHEST JournalItraconazole in the Treatment of Coccidioidomycosis
46 Citations1991Manuel Concha Díaz, Remigio Puente +2 more
Itraconazole is an effective drug to treat coccidioidomycosis with a wide safety margin, it is well tolerated, and the incidence of relapses was low.
Annals of Internal MedicineKetoconazole for Treatment of Chronic Pulmonary Coccidioidomycosis
37 Citations1982JoanM. Ross, BERNARD LEVINE +4 more
Ketoconazole seems to be of significant value in infiltrative pulmonary disease, but seems unable, at the doses used, to change finding in the sputum or to change radiographic findings in chronic cavitary disease.
Antimicrobial Agents and ChemotherapyEfficacy of SCH39304 and fluconazole in a murine model of disseminated coccidioidomycosis
37 Citations1990Karl V. Clemons, L H Hanson +2 more
Results indicate that SCH is an effective therapy for coccidioidomycosis and is superior to FLU in this comparison.
CHEST JournalFluconazole in the Treatment of Persistent Coccidioidomycosis
36 Citations1990Antonino Catanzaro, Joshua Fierer +1 more
Fluconazole is well tolerated at this dose, and in view of its low toxicity, the partial clinical efficacy observed, and the high recurrence rate of chronic coccidioidal infection, it would be justified to try higher doses.
The Pediatric Infectious Disease JournalAmphotericin B and imidazole therapy for coccidioidal meningitis in children
36 Citations1983H. Robert Harrison, D. Phil +4 more
Imidazole therapy of coccidioidal meningitis may be more effective than in AMB in young children, and it offers the advantages of fewer side effects and not requiring intrathecal or cisternal administration.
Antimicrobial Agents and ChemotherapyActivities of the triazole SCH 51048 against Coccidioides immitis in vitro and in vivo
20 Citations1995Karl V. Clemons, Margit Homola +1 more
The activity of the novel triazole SCH 51048 was tested against Coccidioides immitis and showed peak levels in serum of > 14 micrograms/ml, with an estimated half-life of > 12 h, and was 5- to 50-fold or more superior to fluconazole or itraconazole.
Antimicrobial Agents and ChemotherapyEfficacies of two novel azole derivatives each containing a morpholine ring, UR-9746 and UR-9751, against systemic murine coccidioidomycosis
19 Citations1997Karl V. Clemons, David A. Stevens
Both compounds lacked observable toxicity and on a milligram-per-kilogram of body weight basis were > or = 10-fold superior to fluconazole in prolonging survival and clearing infection with C. immitis.
Antimicrobial Agents and ChemotherapyComparison of fluconazole and SDZ89-485 for therapy of experimental murine coccidioidomycosis
19 Citations1990Joshua Fierer, Theo N. Kirkland +1 more
It is concluded that SDZ89-485 is more effective than fluconazole as treatment for experimental systemic coccidioidomycosis in mice, even though flu Conazole achieves higher peak levels in blood.
Archives of Internal MedicineFluconazole Therapy in Coccidioidal Meningitis Maintained With Intrathecal Amphotericin B
17 Citations1995José A. Pérez
This study demonstrates that conversion from amphotericin B to fluconazole was associated with a stable disease course of CM for up to 19 months and delineating both optimal dosage and characteristics of patients likely to respond to flu Conazole therapy alone are needed.
Antimicrobial Agents and ChemotherapyTreatment of murine coccidioidal meningitis with SCH39304
17 Citations1990J Defaveri, Steven Sun +1 more
The triazole SCH39304 was compared with itraconazole and fluconazole for treatment of murine coccidioidal meningitis and was more effective than the other triazoles at equivalent doses.